{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:02:52Z","timestamp":1759341772085},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,7,18]],"date-time":"2011-07-18T00:00:00Z","timestamp":1310947200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1038\/aps.2011.31","type":"journal-article","created":{"date-parts":[[2011,7,18]],"date-time":"2011-07-18T08:31:48Z","timestamp":1310977908000},"page":"1055-1062","source":"Crossref","is-referenced-by-count":10,"title":["Cholera toxin inhibits human hepatocarcinoma cell proliferation in vitro via suppressing ATX\/LPA axis"],"prefix":"10.1038","volume":"32","author":[{"given":"Qi","family":"Xia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-mei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-shan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,18]]},"reference":[{"key":"BFaps201131_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P . Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"BFaps201131_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1586\/egh.09.35","volume":"3","author":"MI Shariff","year":"2009","unstructured":"Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-Robinson SD . Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol 2009; 3: 353\u201367.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"BFaps201131_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/sj.bjc.6604784","volume":"100","author":"TF Greten","year":"2009","unstructured":"Greten TF, Korangy F, Manns MP, Malek NP . Molecular therapy for the treatment of hepatocellular carcinoma. Br J Cancer 2009; 100: 19\u201323.","journal-title":"Br J Cancer"},{"key":"BFaps201131_CR4","first-page":"191","volume":"2","author":"C Braicu","year":"2009","unstructured":"Braicu C, Burz C, Berindan-Neagoe I, Balacescu O, Graur F, Cristea V, et al. Hepatocellular carcinoma: tumorigenesis and prediction markers. Gastroenterol Res 2009; 2: 191\u20139.","journal-title":"Gastroenterol Res"},{"key":"BFaps201131_CR5","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1007\/s11605-007-0322-9","volume":"11","author":"AB Cooper","year":"2007","unstructured":"Cooper AB, Wu J, Lu D, Maluccio MA . Is autotaxin (ENPP2) the link between hepatitis C and hepatocellular cancer? J Gastrointest Surg 2007; 11: 1628\u201334.","journal-title":"J Gastrointest Surg"},{"key":"BFaps201131_CR6","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1016\/S0021-9258(18)45911-X","volume":"267","author":"ML Stracke","year":"1992","unstructured":"Stracke ML, Krutzsch HC, Unsworth EJ, Arestad A, Cioce V, Schiffmann E, et al. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem 1992; 267: 2524\u20139.","journal-title":"J Biol Chem"},{"key":"BFaps201131_CR7","doi-asserted-by":"publisher","first-page":"17492","DOI":"10.1074\/jbc.M601803200","volume":"281","author":"Y Kishi","year":"2006","unstructured":"Kishi Y, Okudaira S, Tanaka M, Hama K, Shida D, Kitayama J, et al. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid. J Biol Chem 2006; 281: 17492\u2013500.","journal-title":"J Biol Chem"},{"key":"BFaps201131_CR8","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1038\/sj.onc.1207377","volume":"23","author":"EJ Black","year":"2004","unstructured":"Black EJ, Clair T, Delrow J, Neiman P, Gillespie DA . Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun. Oncogene 2004; 23: 2357\u201366.","journal-title":"Oncogene"},{"key":"BFaps201131_CR9","doi-asserted-by":"publisher","first-page":"17634","DOI":"10.1074\/jbc.M313927200","volume":"279","author":"K Hama","year":"2004","unstructured":"Hama K, Aoki J, Fukaya M, Kishi Y, Sakai T, Suzuki R, et al. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1 . J Biol Chem 2004; 279: 17634\u20139.","journal-title":"J Biol Chem"},{"key":"BFaps201131_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1476-4598-9-71","volume":"9","author":"JM Wu","year":"2010","unstructured":"Wu JM, Xu Y, Skill NJ, Sheng H, Zhao Z, Yu M, et al. Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma. Mol Cancer; 2010; 9: 71.","journal-title":"Mol Cancer"},{"key":"BFaps201131_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0011-5029(99)90000-7","volume":"45","author":"L Goodman","year":"1999","unstructured":"Goodman L, Segreti J . Infectious diarrhea. Dis Mon 1999; 45: 268\u201399.","journal-title":"Dis Mon"},{"key":"BFaps201131_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/292413a0","volume":"292","author":"J Holmgren","year":"1981","unstructured":"Holmgren J . Actions of cholera toxin and the prevention and treatment of cholera. Nature 1981; 292: 413\u201317.","journal-title":"Nature"},{"key":"BFaps201131_CR13","doi-asserted-by":"publisher","first-page":"9655","DOI":"10.1073\/pnas.91.20.9655","volume":"91","author":"RL Guerrant","year":"1994","unstructured":"Guerrant RL, Fang GD, Thielman NM, Fonteles MC . Role of platelet activating factor in the intestinal epithelial secretory and Chinese hamster ovary cell cytoskeletal responses to cholera toxin. Proc Natl Acad Sci U S A 1994; 91: 9655\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFaps201131_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/jcp.1041020306","volume":"102","author":"J Taylor\u2013Papadimitriou","year":"1980","unstructured":"Taylor\u2013Papadimitriou J, Purkis P, Fentiman IS . Cholera toxin and analogues of cyclic AMP stimulate the growth of cultured human mammary epithelial cells. J Cell Physiol 1980; 102: 317\u201321.","journal-title":"J Cell Physiol"},{"key":"BFaps201131_CR15","first-page":"2294","volume":"41","author":"JF Lechner","year":"1981","unstructured":"Lechner JF, Haugen A, Autrup H, McClendon IA, Trump BF, Harris CC . Clonal growth of epithelial cells from normal adult human bronchus. Cancer Res 1981; 41: 2294\u2013304.","journal-title":"Cancer Res"},{"key":"BFaps201131_CR16","first-page":"1473","volume":"43","author":"YS Cho-Chung","year":"1983","unstructured":"Cho-Chung YS, Clair T, Shepheard C, Berghoffer B . Arrest of hormone-dependent mammary cancer growth in vivo and in vitro by cholera toxin. Cancer Res 1983; 43: 1473\u20136.","journal-title":"Cancer Res"},{"key":"BFaps201131_CR17","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1172\/JCI114923","volume":"86","author":"J Viallet","year":"1990","unstructured":"Viallet J, Sharoni Y, Frucht H, Jensen RT, Minna JD, Sausville EA . Cholera toxin inhibits signal transduction by several mitogens and the in vitro growth of human small-cell lung cancer. J Clin Invest 1990; 86: 1904\u201312.","journal-title":"J Clin Invest"},{"key":"BFaps201131_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1749-6632.2000.tb06554.x","volume":"905","author":"Y Xiao","year":"2000","unstructured":"Xiao Y, Chen Y, Kennedy AW, Belinson J, Xu Y . Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses. Ann N Y Acad Sci 2000; 905: 242\u201359.","journal-title":"Ann N Y Acad Sci"},{"key":"BFaps201131_CR19","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1200\/JCO.2006.08.5571","volume":"25","author":"Z Zhao","year":"2007","unstructured":"Zhao Z, Xiao Y, Elson P, Tan H, Plummer SJ, Berk M, et al. Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer. J Clin Oncol 2007; 25: 2696\u2013701.","journal-title":"J Clin Oncol"},{"key":"BFaps201131_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1046\/j.1365-2249.2001.01432.x","volume":"123","author":"A Kehlen","year":"2001","unstructured":"Kehlen A, Lauterbach R, Santos AN, Thiele K, Kabisch U, Weber E, et al. IL-1 beta- and IL-4-induced down-regulation of autotaxin mRNA and PC-1 in fibroblast-like synoviocytes of patients with rheumatoid arthritis (RA). Clin Exp Immunol 2001; 123: 147\u201354.","journal-title":"Clin Exp Immunol"},{"key":"BFaps201131_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1210\/er.2006-0031","volume":"28","author":"A Wullaert","year":"2007","unstructured":"Wullaert A, van Loo G, Heyninck K, Beyaert R . Hepatic tumor necrosis factor signaling and nuclear factor-kappaB: effects on liver homeostasis and beyond. Endocr Rev 2007; 28: 365\u201386.","journal-title":"Endocr Rev"},{"key":"BFaps201131_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1083\/jcb.200204026","volume":"158","author":"M Umezu-Goto","year":"2002","unstructured":"Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 2002; 158: 227\u201333.","journal-title":"J Cell Biol"},{"key":"BFaps201131_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0076-6879(07)34005-6","volume":"434","author":"AJ Morris","year":"2007","unstructured":"Morris AJ, Smyth SS . Measurement of autotaxin\/lysophospholipase D activity. Methods Enzymol 2007; 434: 89\u2013104.","journal-title":"Methods Enzymol"},{"key":"BFaps201131_CR24","doi-asserted-by":"publisher","first-page":"24408","DOI":"10.1074\/jbc.271.40.24408","volume":"271","author":"HY Lee","year":"1996","unstructured":"Lee HY, Clair T, Mulvaney PT, Woodhouse EC, Aznavoorian S, Liotta LA, et al. Stimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxin. J Biol Chem 1996; 271: 24408\u201312.","journal-title":"J Biol Chem"},{"key":"BFaps201131_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/sj.onc.1203263","volume":"19","author":"SW Nam","year":"2000","unstructured":"Nam SW, Clair T, Campo CK, Lee HY, Liotta LA, Stracke ML . Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells. Oncogene 2000; 19: 241\u20137.","journal-title":"Oncogene"},{"key":"BFaps201131_CR26","first-page":"6938","volume":"61","author":"SW Nam","year":"2001","unstructured":"Nam SW, Clair T, Kim YS, McMarlin A, Schiffmann E, Liotta LA, et al. Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res 2001; 61: 6938\u201344.","journal-title":"Cancer Res"},{"key":"BFaps201131_CR27","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1124\/mol.64.4.994","volume":"64","author":"H Ohta","year":"2003","unstructured":"Ohta H, Sato K, Murata N, Damirin A, Malchinkhuu E, Kon J, et al. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol Pharmacol 2003; 64: 994\u20131005.","journal-title":"Mol Pharmacol"},{"key":"BFaps201131_CR28","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/onc.2010.517","volume":"30","author":"SY Park","year":"2011","unstructured":"Park SY, Jeong KJ, Panupinthu N, Yu S, Lee J, Han JW, et al. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Oncogene 2011; 30: 1351\u20139.","journal-title":"Oncogene"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps201131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201131","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:26:20Z","timestamp":1684412780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps201131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,18]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["BFaps201131"],"URL":"https:\/\/doi.org\/10.1038\/aps.2011.31","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,18]]}}}